Skip to content
10-Q

Quarterly Report

ROCK CREEK PHARMACEUTICALS, INC.

0001144204-16-118075

← back to feed
Filed
Aug 10, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Aug 3, 2016 170.44M sh
Capex Q2 2016 · Jun 30, 2016 $0
Capex Q2 2016 · Jun 30, 2015 $8K
Long Term Debt Q2 2016 · Jun 30, 2016 $2.74M
Long Term Debt Q2 2016 · Dec 31, 2015 $7.52M
Short Term Debt Q2 2016 · Jun 30, 2016 $12.35M
Short Term Debt Q2 2016 · Dec 31, 2015 $12.35M
Cash And Equivalents Q2 2016 · Jun 30, 2016 $185K
Cash And Equivalents Q2 2016 · Dec 31, 2015 $493K
Cash And Equivalents Q2 2016 · Jun 30, 2015 $2.99M
Cash And Equivalents Q2 2016 · Dec 31, 2014 $395K
Stockholders Equity Q2 2016 · Jun 30, 2016 −$12.99M
Stockholders Equity Q2 2016 · Dec 31, 2015 −$10.65M
Current Liabilities Q2 2016 · Jun 30, 2016 $22.02M
Current Liabilities Q2 2016 · Dec 31, 2015 $22.19M
Total Liabilities Q2 2016 · Jun 30, 2016 $24.77M
Total Liabilities Q2 2016 · Dec 31, 2015 $29.72M
Current Assets Q2 2016 · Jun 30, 2016 $194K
Current Assets Q2 2016 · Dec 31, 2015 $1.04M
Total Assets Q2 2016 · Jun 30, 2016 $11.78M
Total Assets Q2 2016 · Dec 31, 2015 $19.07M
Sga Expense Q2 2016 · Jun 30, 2016 $1.91M
Sga Expense Q2 2016 · Jun 30, 2016 $3.14M
Sga Expense Q2 2016 · Jun 30, 2015 $1.65M
Sga Expense Q2 2016 · Jun 30, 2015 $4.99M
Rd Expense Q2 2016 · Jun 30, 2016 $113K
Rd Expense Q2 2016 · Jun 30, 2016 $245K
Rd Expense Q2 2016 · Jun 30, 2015 $376K
Rd Expense Q2 2016 · Jun 30, 2015 $850K
Net Income Q2 2016 · Jun 30, 2016 −$2.79M
Net Income Q2 2016 · Jun 30, 2016 −$5.49M
Net Income Q2 2016 · Jun 30, 2015 −$843K
Net Income Q2 2016 · Jun 30, 2015 −$1.18M
Operating Income Q2 2016 · Jun 30, 2016 −$2.02M
Operating Income Q2 2016 · Jun 30, 2016 −$3.38M
Operating Income Q2 2016 · Jun 30, 2015 −$2.02M
Operating Income Q2 2016 · Jun 30, 2015 −$5.84M